New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Decrease noted in lung cancer cases over past five years

Decrease noted in lung cancer cases over past five years

by Elana Gotkine HealthDay ReporterThe number of new cases of lung cancer has decreased over the last five years, but screening rates are still low, according to a report published by the American Lun
Oncology December 23,2023
Decrease noted in lung cancer cases over past five years

Decrease noted in lung cancer cases over past five years

by Elana Gotkine HealthDay ReporterThe number of new cases of lung cancer has decreased over the last five years, but screening rates are still low, according to a report published by the American Lun
Oncology December 23,2023
Targeted screening could prevent one in six prostate cancer deaths

Targeted screening could prevent one in six prostate cancer deaths

byUniversity College LondonMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Nearly one in six deaths from prostate
Oncology December 23,2023
Targeted screening could prevent one in six prostate cancer deaths

Targeted screening could prevent one in six prostate cancer deaths

byUniversity College LondonMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Nearly one in six deaths from prostate
Oncology December 23,2023
New algorithm detects even the smallest cancer metastases across the entire mouse body

New algorithm detects even the smallest cancer metastases across the entire mouse body

byHelmholtz Association of German Research CentresDeepMACT makes use of artificial intelligence to find even the smallest metastases in the entire mouse body. The picture shows single disseminat
Oncology December 23,2023
New algorithm detects even the smallest cancer metastases across the entire mouse body

New algorithm detects even the smallest cancer metastases across the entire mouse body

byHelmholtz Association of German Research CentresDeepMACT makes use of artificial intelligence to find even the smallest metastases in the entire mouse body. The picture shows single disseminat
Oncology December 23,2023
Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in some breast cancer

Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in some breast cancer

byScience China PressThe CDK4/6 inhibitors-resistant breast cancer cells expressed more Cyclin D1 and CDK4 proteins than the parental cells (Upper left). PI3K pathway was hyper-activated in the
Oncology December 23,2023
Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in some breast cancer

Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in some breast cancer

byScience China PressThe CDK4/6 inhibitors-resistant breast cancer cells expressed more Cyclin D1 and CDK4 proteins than the parental cells (Upper left). PI3K pathway was hyper-activated in the
Oncology December 23,2023
National quality improvement initiative successfully helps address pandemic-related cancer screening deficits

National quality improvement initiative successfully helps address pandemic-related cancer screening deficits

byAmerican College of SurgeonsMean Monthly Screening Test Volumes in April Through November. 2021 April and May 2021 is the preintervention period. Vertical dotted line indicates the start of th
Oncology December 23,2023
National quality improvement initiative successfully helps address pandemic-related cancer screening deficits

National quality improvement initiative successfully helps address pandemic-related cancer screening deficits

byAmerican College of SurgeonsMean Monthly Screening Test Volumes in April Through November. 2021 April and May 2021 is the preintervention period. Vertical dotted line indicates the start of th
Oncology December 23,2023
Researchers look at post menopause as key factor in endometrial cancer

Researchers look at post menopause as key factor in endometrial cancer

byMayo ClinicCredit: CC0 Public DomainEndometrial cancer is the most common gynecological malignancy in the U.S. and the fourth most common cancer among women. In addition, endometrial cancer in
Oncology December 23,2023
Researchers look at post menopause as key factor in endometrial cancer

Researchers look at post menopause as key factor in endometrial cancer

byMayo ClinicCredit: CC0 Public DomainEndometrial cancer is the most common gynecological malignancy in the U.S. and the fourth most common cancer among women. In addition, endometrial cancer in
Oncology December 23,2023
National prostate cancer trial currently testing therapy based on molecular discovery

National prostate cancer trial currently testing therapy based on molecular discovery

byCleveland ClinicCredit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI163498A new prostate cancer therapy in clinical trials could treat patients resistant to treatment t
Oncology December 23,2023
National prostate cancer trial currently testing therapy based on molecular discovery

National prostate cancer trial currently testing therapy based on molecular discovery

byCleveland ClinicCredit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI163498A new prostate cancer therapy in clinical trials could treat patients resistant to treatment t
Oncology December 23,2023
Researchers identify immune-suppressing target in glioblastoma

Researchers identify immune-suppressing target in glioblastoma

byUniversity of Texas M. D. Anderson Cancer CenterGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Researchers at The University of Texas MD Anderson Cancer Center have identified a
Oncology December 23,2023
Researchers identify immune-suppressing target in glioblastoma

Researchers identify immune-suppressing target in glioblastoma

byUniversity of Texas M. D. Anderson Cancer CenterGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Researchers at The University of Texas MD Anderson Cancer Center have identified a
Oncology December 23,2023
Scientists discover metabolic feature that allows melanoma cells to spread

Scientists discover metabolic feature that allows melanoma cells to spread

by Katie Regan,UT Southwestern Medical CenterResearchers involved in the study include (from left) Drs. Brandon Faubert, Alpaslan Tasdogan, Sean Morrison, and Ralph DeBerardinis. Credit: UTSWRes
Oncology December 23,2023
Scientists discover metabolic feature that allows melanoma cells to spread

Scientists discover metabolic feature that allows melanoma cells to spread

by Katie Regan,UT Southwestern Medical CenterResearchers involved in the study include (from left) Drs. Brandon Faubert, Alpaslan Tasdogan, Sean Morrison, and Ralph DeBerardinis. Credit: UTSWRes
Oncology December 23,2023
How optoacoustic imaging plays a role in assessing the success of breast cancer surgery

How optoacoustic imaging plays a role in assessing the success of breast cancer surgery

byAgency for Science, Technology and Research (A*STAR), SingaporeEquipment set-up. (A) Schematic of the handheld US-OT probe placed in heavy water tank on the specimen. The probe is then moved s
Oncology December 23,2023
How optoacoustic imaging plays a role in assessing the success of breast cancer surgery

How optoacoustic imaging plays a role in assessing the success of breast cancer surgery

byAgency for Science, Technology and Research (A*STAR), SingaporeEquipment set-up. (A) Schematic of the handheld US-OT probe placed in heavy water tank on the specimen. The probe is then moved s
Oncology December 23,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com